Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 14 citing Shibata: Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged.... (0.08 sec) 

Causes and metabolic consequences of fatty liver


N Stefan, K Kantartzis, HU Haring - Endocrine Reviews, 2008 - Endocrine Soc
Type 2 diabetes and cardiovascular disease represent a serious threat to the
health of the population worldwide. Although overall adiposity and particularly
visceral adiposity are established risk factors for these diseases, in the ...
Cited by 15 - Related articles - All 4 versions

[PDF] Impact of non-alcoholic fatty liver disease on accelerated metabolic complications


JG FAN - Journal of digestive diseases, 2008 - zhzfg.com
Insulin resistance is the basis of both non-alcoholic fatty liver disease
(NAFLD) and metabolic syndrome (MetS), the two conditions are often found in the
same individual. The mortality of patients with NAFLD is significantly ...
Cited by 15 - Related articles - View as HTML - BL Direct - All 6 versions

Plasma fetuin-A levels and the risk of type 2 diabetes

- diabetesjournals.org
N Stefan, A Fritsche, C Weikert, H Boeing, HG … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Plasma fetuin-A levels were positively associated with diabetes risk
after adjustment for age (relative risk [RR] for extreme quintiles 1.75 [95% CI
1.32–2.31]; RR for 10 μg/ml 1.04 [1.03–1.06]). The association ...
Cited by 11 - Related articles - All 6 versions

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

- geyseco.info [PDF] 
R Taylor - Diabetologia, 2008 - Springer
Abstract The metabolic abnormalities of type 2 diabetes can be reversed
reproducibly by bariatric surgery. By quantifying the major pathophysiological
abnormalities in insulin secretion and insulin action after surgery, the ...
Cited by 11 - Related articles - All 7 versions

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a …


K Kantartzis, C Thamer, A Peter, J Machann, F … - British Medical Journal, 2009 - gut.bmj.com
Objective: Lifestyle intervention with diet modification and increase in
physical activity is effective for reducing hepatic steatosis in patients with
non-alcoholic fatty liver disease (NAFLD). However, for a similar weight ...
Cited by 4 - Related articles - All 4 versions

Serum Adipocyte Fatty Acid–Binding Protein Levels Are Associated With Nonalcoholic Fatty …


H Koh… - Diabetes care, 2009 - Am Diabetes Assoc
RESULTS—A-FABP levels, defined as more than a moderate degree of fatty liver
compared with men, those without metabolic syndrome, and those without NAFLD,
were higher in women, patients with metabolic syndrome, and patients with ...
Cited by 2 - Related articles - All 4 versions

Gender differences in insulin resistance, body composition, and energy balance


EB Geer, W Shen - Gender Medicine, 2009 - Elsevier
Results: For a given body mass index, men were reported to have more lean mass,
women to have higher adiposity. Men were also found to have more visceral and
hepatic adipose tissue, whereas women had more peripheral or subcutaneous ...
Cited by 2 - Related articles - All 2 versions

Non-alcoholic fatty liver disease from pathogenesis to management: an update


G Musso, R Gambino, M Cassader - Obesity Reviews, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles

Adiponectina e seu papel na proteção contra a doença hepática gordurosa na obesidade: …

- scielo.br
Y WANG, M ZHOU, KSL LAM, A XU - Arq Bras Endocrinol Metab - SciELO Brasil
Adiponectin is an insulin-sensitizing adipokine possessing multiple beneficial
effects on obesity-related medical complications. This adipokine is secreted
from adipocytes into the circulation as three oligomeric isoforms, ...
Related articles - Cached

Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and …


Y Wang, M Zhou, KSL Lam, A Xu - Arquivos Brasileiros de Endocrinologia & Metabologia, 2009 - SciELO Brasil
Adiponectin is an insulin-sensitizing adipokine possessing multiple beneficial
effects on obesity-related medical complications. This adipokine is secreted
from adipocytes into the circulation as three oligomeric isoforms, ...
Related articles - Cached - All 5 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google